Comments

Aldeyra Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Aldeyra Therapeutics (ALDX) operate in?

Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ALDXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.18

0.020.93%

At close: -

$2.18

0.000.00%

After Hours: 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Forecast

News Earnings Aldeyra Therapeutics (ALDX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Aldeyra Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ALDX | Benzinga

Explore Aldeyra Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALDX.

Open	$2.17
Close	$2.18
Volume / Avg.	1.09M / 1.72M
Day Range	$2.14 - $2.30
52 Wk Range	1.14 - 7.20
Market Cap	$129.82M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	10.01%
Days to Cover	4.28

Recent News

Crude Oil Dips 7%; ISM Services PMI Falls In March

Avi Kapoor

Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall

Avi Kapoor

FDA Rejects Aldeyra's Reproxalap For Dry Eye Disease Again, Citing Efficacy Concerns

The FDA rejected Aldeyra's resubmission for reproxalap, citing efficacy concerns. The company plans another trial and aims to resubmit the NDA by mid-2025.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.17
Close	$2.18
Volume / Avg.	1.09M / 1.72M
Day Range	$2.14 - $2.30
52 Wk Range	1.14 - 7.20
Market Cap	$129.82M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	35
Short Interest	10.01%
Days to Cover	4.28

About Aldeyra Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-g...

Got Questions? Ask

What is ALDX's 200-day MA?

Compare ALDX performance to the market?

How is ALDX's price-to-book ratio?

What is ALDX's all-time low price?

What is ALDX's net income trend?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aldeyra Therapeutics (ALDX) stock?

You can purchase shares of Aldeyra Therapeutics (NASDAQ:ALDX) through any online brokerage.

View our list of the best stock brokerages

Who are Aldeyra Therapeutics (ALDX) competitors?

Other companies in Aldeyra Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), 4D Molecular Therapeutics (NASDAQ:FDMT), Quoin Pharmaceuticals (NASDAQ:QNRX), Korro Bio (NASDAQ:KRRO) and Larimar Therapeutics (NASDAQ:LRMR).

What is the forecast, or price target, for Aldeyra Therapeutics (ALDX) stock?

Aldeyra Therapeutics has a consensus price target of $9.25.

What is the current price for Aldeyra Therapeutics (ALDX)?

The stock price for Aldeyra Therapeutics (NASDAQ: ALDX) is $2.18 last updated May 9, 2025 at 4:00 PM EDT.

Does Aldeyra Therapeutics (ALDX) pay a dividend?

There are no upcoming dividends for Aldeyra Therapeutics.

When is Aldeyra Therapeutics (NASDAQ:ALDX) reporting earnings?

Aldeyra Therapeutics’s Q2 earnings are confirmed for Thursday, July 31, 2025.

Is Aldeyra Therapeutics (ALDX) going to split?

There is no upcoming split for Aldeyra Therapeutics.

What sector and industry does Aldeyra Therapeutics (ALDX) operate in?

Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.